Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid × Anthracyclines × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Leukemia, Myeloid, Acute 2 Cardiotoxicity 2 Pathologic Complete Response 1 Neoplasms, Second Primary 1 Leukemia 1 Cardiovascular Diseases 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

fludarabine 6 Whole-Body Irradiation 6 Cyclophosphamide 6 fludarabine phosphate 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Busulfan 4 venetoclax 3 Azacitidine 3 gilteritinib 2 asciminib 2 aldesleukin 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Interleukin-2 2 Cytarabine 2 Bone Marrow Transplantation 2 spartalizumab 1 sabatolimab 1 ponatinib 1 nilotinib 1 nicotinamide-beta-riboside 1 methanesulfonic acid 1 interferon gamma-1b 1 enasidenib 1 blinatumomab 1 Thiotepa 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡